Amoli is the vision and perseverance of its Chairman, Mr. Umed Doshi a widely respected entrepreneur with more than 5 decades of rich experience.

Amoli has a successful track record in the pharmaceutical and allied industry. Making a beginning as a manufacturer of API’s and Intermediates, it made successful forays in the field of ‘Contract Research’ and ‘Custom Synthesis’. Amoli has been working collaboratively with some of the leading global healthcare players.

• 700 strong dedicated work force.
• 2 state-of the art manufacturing plants
• USFDA and EDQM approved site
• Plants are CGMP and SHE complaint
• Well equipped R&D center (Process Development)
• Custom Synthesis and Contract Manufacturing
• Exports to 65 Countries
• Presence in Europe, Russia, China, Japan, South East Asia, Middle East
• Fast growing and well integrated healthcare group